Clinical Trials Logo

Clinical Trial Summary

To explore the association among gene, TCM pattern, TCM tongue diagnosis and TCM pulse diagnosis with the DNA Exome sequencing tools for Sjögren's syndrome


Clinical Trial Description

Objective: To explore the association among gene, TCM pattern, TCM tongue diagnosis and TCM pulse diagnosis with the DNA Exome sequencing tools for Sjögren's syndrome

Method:

This study wants to establish the reference value of DNA gene variants of healthy control for comparing with the Sjögren's syndrome subjects. And the investigators want to use the DNA Exome sequencing tools, proteomics and oral microbiome to explore the association of gene expression between at least 30 Sjögren's syndrome subjects and at least 10 healthy control subjects. Finally, the investigators also analyze the association among gene expression, proteomics and oral microbiome, TCM pattern, TCM tongue diagnosis, TCM pulse diagnosis, and heart rate variability (HRV) for this purpose.

Expected Results:

1. To evaluate the difference among TCM pattern, TCM tongue diagnosis, TCM pulse diagnosis, and HRV for the Sjögren's syndrome and healthy control.

2. To evaluate the immunity-related gene expression for the Sjögren's syndrome and healthy control.

3. To evaluate the proteomics for the Sjögren's syndrome and healthy control.

4. To evaluate the oral microbiome for the Sjögren's syndrome and healthy control.

5. To evaluate the association among the immunity-related gene expression, SSA, SSB and RF.

Keyword: Sjögren's syndrome, Immune regulation, Gene modulation, TCM pattern, TCM tongue diagnosis, TCM pulse diagnosis, proteomics, oral microbiome ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03935373
Study type Observational
Source Taipei Veterans General Hospital, Taiwan
Contact
Status Active, not recruiting
Phase
Start date April 1, 2019
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05946941 - A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome Phase 3
Completed NCT05633524 - HRR as a Novel Biomarker in Sjögren's Syndrome
Terminated NCT02843659 - Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome Phase 2
Completed NCT04129164 - A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome Phase 2
Completed NCT04798911 - SS-INQ Information Needs Questionnaire in Sjögren's Syndrome
Recruiting NCT05605665 - Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome Phase 1/Phase 2
Completed NCT02833311 - e-Mobile Tablet for People With Chronic Conditions N/A
Completed NCT04572841 - Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) Phase 2
Completed NCT04111341 - A Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome. Phase 2
Recruiting NCT03060005 - Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ? N/A
Terminated NCT01316770 - Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects Phase 2
Completed NCT02422407 - A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome N/A
Completed NCT01160666 - Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome Phase 2
Active, not recruiting NCT02849093 - Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome. N/A
Active, not recruiting NCT02112019 - Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome N/A
Recruiting NCT03983408 - Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease N/A
Completed NCT00873496 - Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients N/A
Completed NCT05680064 - The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome N/A
Recruiting NCT02855658 - Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome Phase 2
Recruiting NCT02110446 - Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome Phase 2